antibodies
Impaired Tolerance of Self-Tissues Leads to Autoantibodies Against IFN-I
Autoantibodies against type I interferons (IFN-I) increase susceptibility to severe infections
Rejuvenation of the Immune System: A New Method to Combat Age-Related Immunity Decline
Altering Stem Cell Balance to Combat Aging of the Immune System
Autoantibodies to Interferons Are Not Associated with Chronic Fatigue after COVID-19
Only 1.6% of patients with post-COVID syndrome had autoantibodies to IFN-β
Autoantibodies to Type I Interferons in COVID-19 Patients
Autoantibodies to tissues, immune cells and interferons complicate the course of COVID-19
Antibody-Free Protection: The Effectiveness of COVID-19 Vaccination in Patients with B-Cell Deficiency
Enhanced T-cell responses with B-cell deficiency reduce the risk of severe COVID-19 by 5-fold
Protection Against Omicron: New Vaccines on the Horizon
The World Health Organization has recommended a monovalent vaccine based on the Kraken strain, a subvariant of Omicron
Coronavirus Pyrola: Do Vaccines and Previous Infection Protect Against Other Strains?
Mutations in the Spike Protein Help Pyrola Evade Immune Protection
Indigenous Peoples in Australia More Severely Ill COVID-19
The reason for the weak antibody response is chronic diseases
IgM Antibodies Protect Against Delta and Omicron Strains
IgM antibodies derived from memory B cells neutralize a wide range of coronavirus strains
Post-Vaccination and Natural COVID-19 Antibodies: Which Protect Better?
S-protein in a closed state as the basis of future vaccines
Common Cold Immunity Protects Children From COVID-19
Protein S2 – a promising basis for future coronavirus vaccines
How Long Do Antibodies Persist After COVID-19
After natural SARS-CoV-2, protection against reinfection persists for about two years
What Level of Neutralizing Antibodies Protects Against COVID-19
Antibody titers predict the protective efficacy of vaccines
COVID-19 Symptoms Depend on The Infecting Dose
SARS-CoV-2 dose affects seroconversion and fever
The dominant role of IgA antibodies in the early stage of COVID-19
Most of the IgA is in the mucous membranes, the entrance gate of the coronavirus
Immunological memory for SARS-CoV-2. Five components of the immune response
How coronavirus immunity is formed and how long it lasts. Is immune memory produced and stored for how long in mild and asymptomatic COVID-19
Natural and Post-Vaccination COVID-19 Antibodies: What Is Most Important
Protective level of antibodies to SARS-CoV-2: when it is produced, what it depends on, and how much is stored
Herd immunity to COVID-19
How do cross-reactive memory T cells affect herd immunity to SARS-CoV-2
A way to successful vaccination
Зачем нужны вакцины. Как они работают. Что повышает их эффективность
Russian microbiologists have isolated antibodies that block the reproduction of SARS-CoV-2
Single sorting of B-lymphocytes will increase vaccines safety and make COVID-19 treatment more effective.